SEC Form 4 · accession 0000899243-15-005119
Larimar Therapeutics, Inc. · LRMR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Avi Y. Goldberg
Director
Period of report
Sep 18, 2015
Accepted (ET)
Sep 21, 2015 · 9:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374690
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 18, 2015 | S | 5,000 | $45.00 | D | 53,734 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale of shares by the Reporting Person was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.